{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:14:42Z","timestamp":1783397682107,"version":"3.54.6"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82400445"],"award-info":[{"award-number":["82400445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270404"],"award-info":[{"award-number":["82270404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14677-x","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:55:34Z","timestamp":1778590534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing specialist competence in clinical pathways for left ventricular hypertrophy: design and evaluation of a competency-based curriculum"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanjia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"14677_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","volume":"20","author":"TG Martin","year":"2023","unstructured":"Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol. 2023;20:347\u201363.","journal-title":"Nat Rev Cardiol"},{"key":"14677_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/ejhf.3339","volume":"26","author":"SA Muller","year":"2024","unstructured":"Muller SA, Peiro-Aventin B, Biagioni G, et al. Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis. Eur J Heart Fail. 2024;26:2025\u201334.","journal-title":"Eur J Heart Fail"},{"key":"14677_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","volume":"45","author":"M Pieroni","year":"2024","unstructured":"Pieroni M, Namdar M, Olivotto I, Desnick RJ. Anderson-Fabry disease management: role of the cardiologist. Eur Heart J. 2024;45:1395\u2013409.","journal-title":"Eur Heart J"},{"key":"14677_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5334\/gh.1262","volume":"18","author":"D Brito","year":"2023","unstructured":"Brito D, Albrecht FC, de Arenaza DP, et al. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Glob Heart. 2023;18:59.","journal-title":"Glob Heart"},{"key":"14677_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.31083\/j.rcm2306196","volume":"23","author":"M Pieroni","year":"2022","unstructured":"Pieroni M, Ciabatti M, Graziani F, et al. The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies. Rev Cardiovasc Med. 2022;23:196.","journal-title":"Rev Cardiovasc Med"},{"key":"14677_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M, Moon JC, Arbustini E, et al. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77:922\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"14677_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","volume":"13","author":"S Dorbala","year":"2020","unstructured":"Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging. 2020;13:1368\u201383.","journal-title":"JACC Cardiovasc Imaging"},{"key":"14677_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12909-022-03228-7","volume":"22","author":"B Maxner","year":"2022","unstructured":"Maxner B, Hansra B, Sibai D, et al. Developing a curriculum to improve cardiology fellows\u2019 training in pregnancy and cardiovascular disease. BMC Med Educ. 2022;22:166.","journal-title":"BMC Med Educ"},{"key":"14677_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1186\/s12909-025-07859-4","volume":"25","author":"JK Li","year":"2025","unstructured":"Li JK, Zhao YC, Wu SQ, et al. The pharmacy graduate global competence evaluation scale (PGGCES): a nationwide study in China. BMC Med Educ. 2025;25:1247.","journal-title":"BMC Med Educ"},{"key":"14677_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","volume":"22","author":"A Linhart","year":"2020","unstructured":"Linhart A, Germain DP, Olivotto I, et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020;22:1076\u201396.","journal-title":"Eur J Heart Fail"},{"key":"14677_CR11","first-page":"17","volume":"39","author":"Heart Failure Core Group of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association","year":"2024","unstructured":"Heart Failure Core Group of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association. Clinical Pathway of Diagnosis and Treatment of Left Ventricular Hypertrophy: Chinese Expert Consensus 2023. Chin Circulation J. 2024;39:17\u201328.","journal-title":"Chin Circulation J"},{"key":"14677_CR12","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"A World Medical","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14677-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:18:42Z","timestamp":1783394322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14677-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14677"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14677-x","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, which determined that formal ethics approval was not required as the study involved an anonymous survey of physicians and did not include patient data, biological materials, or identifiable personal information. All procedures were conducted in accordance with the ethical principles of the Declaration of Helsinki. Participation in the study was entirely voluntary. All participants were informed about the objectives and procedures of the study, and electronic informed consent was obtained prior to questionnaire completion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}